Skip to Content

Xtant Medical Holdings Inc XTNT

Morningstar Rating
$0.72 +0.01 (1.80%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

XTNT is trading at a 830% premium.
Price
$0.72
Fair Value
$4.55
Uncertainty
Very High
1-Star Price
$9.72
5-Star Price
$4.45
Economic Moat
Qqgjp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XTNT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.71
Day Range
$0.690.78
52-Week Range
$0.601.45
Bid/Ask
$0.68 / $0.96
Market Cap
$94.15 Mil
Volume/Avg
46,927 / 87,663

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.94
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
215

Comparables

Valuation

Metric
XTNT
SIBN
7XC
Price/Earnings (Normalized)
Price/Book Value
1.973.87
Price/Sales
0.944.32
Price/Cash Flow
Price/Earnings
XTNT
SIBN
7XC

Financial Strength

Metric
XTNT
SIBN
7XC
Quick Ratio
0.928.633.78
Current Ratio
2.349.764.66
Interest Coverage
−0.05−13.62−28.71
Quick Ratio
XTNT
SIBN
7XC

Profitability

Metric
XTNT
SIBN
7XC
Return on Assets (Normalized)
−10.63%−7.83%−0.01%
Return on Equity (Normalized)
−19.90%−10.72%−0.02%
Return on Invested Capital (Normalized)
−9.14%−10.92%−0.22%
Return on Assets
XTNT
SIBN
7XC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
MfkynhmDpgxyb$179.1 Bil
Stryker Corp
SYK
KdnkbsjxGtlbr$125.2 Bil
Boston Scientific Corp
BSX
BtflfzgyFcdjtc$114.7 Bil
Medtronic PLC
MDT
YfzwkjrSvtdc$98.8 Bil
Edwards Lifesciences Corp
EW
DphltxpbqRkngfn$53.9 Bil
DexCom Inc
DXCM
PmvslqtwrXcgp$44.8 Bil
Koninklijke Philips NV ADR
PHG
HpvhqygdSfkzy$24.5 Bil
Zimmer Biomet Holdings Inc
ZBH
ZqvlcfxwsChn$21.9 Bil
Steris PLC
STE
RwmwjltzvPjsqk$21.8 Bil
Align Technology Inc
ALGN
BzsmvrxvnGfsyh$18.1 Bil

Sponsor Center